GE HealthCare will join more than 4,300 exhibitors from over 180 countries at this gathering of leading innovators, suppliers, and healthcare professionals.
The partnership centers on incorporating Diagnoly’s Fetoly platform into GE HealthCare’s established Voluson women’s health ultrasound systems, marking a significant advancement in prenatal diagnostic technology.
Through its wholly owned healthcare subsidiary, NSIA Advanced Medical Services Limited (MedServe), the Authority has partnered with GE HealthCare to launch an ambitious diagnostic services expansion program.
Recon DL is the first mammography technology to combine deep learning with iterative reconstruction methods to enhance digital breast tomosynthesis (DBT) image quality.
The acquisition aims to connect ambulatory care centers, teleradiology services, and hospital systems through unified imaging technology.